MediPoint: Cardiac Assist Devices - Current and Pipeline Products: New Research Report Available at Fast Market Research
While heart transplantation remains the gold standard and preferred treatment option for patients with advanced Congestive Heart Failure (CHF), the number of transplant candidates far exceeds the donor pool. This significant limitation has prompted considerable, continued interest in the development of Cardiac Assist Devices (CAD) that are capable of supporting patients with severe CHF, either until donor hearts become available or as an alternative to heart transplantation for long-term use.
View full press release